Aeon Global Health. Revenue Growth Rates (AGHC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Aeon Global Health Corp.  (AGHC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

AGHC's Revenue Growth by Quarter and Year

Aeon Global Health.'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AGHC Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
4th Quarter June 3.06
3rd Quarter March 3.55
2nd Quarter December 3.74
1st Quarter September 3.36
FY 13.71





AGHC Revenue fourth quarter 2019 Y/Y Growth Comment
Aeon Global Health Corp. reported decline in Revenue in the fourth quarter 2019 by -24.67% to $ 3.06 millions, from the same quarter in 2018.
Despite modest results in the fourth quarter 2019, contraction in Aeon Global Health Corp.'s Revenue appears to be smaller than Company's recent average decline.

Looking into fourth quarter 2019 results within Medical Laboratories industry 28 other companies have achieved higher Revenue growth. While Aeon Global Health Corp.' s Revenue fall of -24.67% ranks overall at the positon no. 3870 in the fourth quarter 2019.


AGHC Revenue ( Y/Y Growth %) 2019
 2018 2017 2016
4th Quarter June -24.67 % - - -
3rd Quarter March - - - -
2nd Quarter December - - - -
1st Quarter September - - - -
FY   237.64 % - - -

Financial Statements
Aeon Global Health.'s fourth quarter 2019 Revenue $ 3.06 millions AGHC's Income Statement
Aeon Global Health.'s fourth quarter 2018 Revenue $ 4.06 millions Quarterly AGHC's Income Statement


AGHC Revenue (Quarter on Quarter Growth %)

 2019
 2018 2017 2016
4th Quarter June -13.85 % - - -
3rd Quarter March -5.08 % - - -
2nd Quarter December 11.31 % - - -
1st Quarter September -17.24 % - - -
FY (Year on Year)   237.64 % - - -


Back to AGHC Growth rate Comparisons >> Back to AGHC Growth rate Comparisons >>


Revenue fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #29
Healthcare Sector #515
Overall #3870

Revenue Y/Y Growth Statistics
High Average Low
-87.01 % -87.01 % -87.01 %
(Jun 30 2019)  
Revenue fourth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #29
Healthcare Sector #515
Overall #3870
Revenue Y/Y Growth Statistics
High Average Low
-87.01 % -87.01 % -87.01 %
(Jun 30 2019)  

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Aeon Global Health.'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
201.94 % 35.71 % -69.45 %
(Jun 30 2018)  


AGHC's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2019 Aeon Global Health Corp. disclosed drop in Revenue from the third quarter by -13.85% to $ 3.06 millions, from $ 3.55 millions achived in the previous reporting period.

Within Medical Laboratories industry 20 other companies have achieved higher Revenue quarter on quarter growth. While Aeon Global Health.'s Revenue growth quarter on quarter, overall rank is 4109.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #21
Healthcare Sector #919
Overall #4109
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #21
Healthcare Sector #919
Overall #4109
Revenue Q/Q Growth Statistics
High Average Low
201.94 % 35.71 % -69.45 %
(Jun 30 2018)  


AGHC's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2019 Aeon Global Health Corp. disclosed drop in Revenue from the third quarter by -13.85% to $ 3.06 millions, from $ 3.55 millions achived in the previous reporting period.

Within Medical Laboratories industry 20 other companies have achieved higher Revenue quarter on quarter growth. While Aeon Global Health.'s Revenue growth quarter on quarter, overall rank is 4109.


Aeon Global Health.'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2019)		 12 Months Ending
(Dec 31 2018)		 12 Months Ending
(Sep 30 2018)		 12 Months Ending
(Jun 30 2018)		 12 Months Ending
(Mar 31 2018)
Cumulative Revenue 12 Months Ending $ 13.70 $ 14.70 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) -6.78 % - - - -
Seq. Revenue Growth (TTM) Overall Ranking # 3174 # 0 # 0 # 0 # 0


Cumulative Revenue growth Comment


Aeon Global Health Corp. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 24
Sector # 399
S&P 500 # 3174
Cumulative Revenue growth Comment


Aeon Global Health Corp. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 24
Sector # 399
S&P 500 # 3174




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AGHC's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue drop for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2019
Matinas Biopharma Holdings Inc 0.00%$ -0.001 millions
Baxter International Inc -0.07%$ -0.070 millions
Integer Holdings Corporation-0.09%$ -0.086 millions
Abbvie Inc -0.28%$ -0.278 millions
Anika Therapeutics Inc -0.43%$ -0.426 millions
Rockwell Medical inc -0.45%$ -0.453 millions
Enveric Biosciences Inc -0.55%$ -0.549 millions
Alimera Sciences Inc-0.57%$ -0.568 millions
Bio rad Laboratories Inc -0.57%$ -0.572 millions
Nature s Sunshine Products inc -0.59%$ -0.594 millions
Allergan plc-0.83%$ -0.827 millions
Zimmer Biomet Holdings Inc -0.95%$ -0.946 millions
Agenus Inc-1.13%$ -1.130 millions
Magellan Health inc -1.25%$ -1.247 millions
Sonida Senior Living Inc -1.31%$ -1.309 millions
Davita Inc -1.53%$ -1.533 millions
Enovis Corp-1.80%$ -1.798 millions
American Renal Associates Holdings Inc -1.81%$ -1.808 millions
Endo International Plc-2.09%$ -2.094 millions
Reliv International Inc-2.40%$ -2.396 millions
3m Company-2.61%$ -2.610 millions
Nevro Corp -2.61%$ -2.611 millions
Alector Inc -2.70%$ -2.701 millions
Envista Holdings Corporation-2.90%$ -2.904 millions
Amneal Pharmaceuticals Inc -2.94%$ -2.938 millions
Vivosim Labs Inc -3.05%$ -3.048 millions
Amgen Inc -3.10%$ -3.103 millions
Dentsply Sirona Inc -3.14%$ -3.138 millions
Perrigo Company Plc-3.15%$ -3.152 millions
Livanova Plc-3.59%$ -3.593 millions


About Aeon Global Health. Revenue Growth Rates (AGHC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.